Literature DB >> 25002733

Complete cytogenetic response, not deep molecular response, is associated with survival in chronic myeloid leukemia.

Hagop Kantarjian, Jorge E Cortes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25002733     DOI： 10.1200/JCO.2014.56.0904

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Molecular monitoring in chronic myeloid leukemia-how low can you go?

Authors:  Susan Branford
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 2.  Chronic myeloid leukemia: reminiscences and dreams.

Authors:  Tariq I Mughal; Jerald P Radich; Michael W Deininger; Jane F Apperley; Timothy P Hughes; Christine J Harrison; Carlo Gambacorti-Passerini; Giuseppe Saglio; Jorge Cortes; George Q Daley
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941

3.  Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia.

Authors:  Z Chen; L J Medeiros; H M Kantajian; L Zheng; Z Gong; K P Patel; H Xiong; W Wang; J E Cortes; S Hu
Journal:  Blood Cancer J       Date:  2017-02-03       Impact factor: 11.037

4.  Overexpression of chromodomain helicase DNA binding protein 5 (CHD5) inhibits cell proliferation and induces cell cycle arrest and apoptosis in chronic myeloid leukemia.

Authors:  Shilin Xiong; Qitao Yan; Yiqi Peng; Sheng Huang; Rui Zhao
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.